Bruker Corp
NASDAQ:BRKR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
48.25
94.27
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bruker Corp
Bruker Corp
Total Receivables
Bruker Corp
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bruker Corp
NASDAQ:BRKR
|
Total Receivables
$712.9m
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Receivables
$9.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Receivables
$4.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Receivables
$637.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Receivables
$1.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Receivables
$3.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
12%
|
|
Bruker Corp
Glance View
Bruker Corporation, a prominent entity in the analytical instrumentation sector, traces its roots back to Germany. Wholly devoted to advancing science and industry through meticulous precision, Bruker has carved out a niche in creating sophisticated analytical instruments that enable comprehensive research and diagnostics. Their portfolio spans a diverse range of technologies, including mass spectrometry, magnetic resonance imaging, X-ray analysis, and molecular spectroscopy, all meticulously designed to meet the exacting demands of their clientele. These sophisticated tools empower researchers, scientists, and industrial operators to obtain insights into the fundamental properties of materials and substances, thereby driving forward discoveries in medicine, chemistry, and material science. Bruker's financial health rests on a business model grounded in both innovation and strategic expansion. They generate revenue through the sale of their high-precision instruments as well as a steadily growing service segment that ensures their equipment remains at the cutting edge of functionality and reliability. Additionally, the company pursues collaborative ventures with academic institutions and industrial partners, creating a synergistic loop for product and market development. This strategic approach not only fortifies their market position but also nurtures long-term relationships, underpinning recurring revenues from service contracts and incremental technology upgrades. With a clear focus on driving quality and innovation, Bruker Corporation thrives in a competitive landscape, catering to the evolving needs of scientific discovery and industrial precision.
See Also
What is Bruker Corp's Total Receivables?
Total Receivables
712.9m
USD
Based on the financial report for Sep 30, 2024, Bruker Corp's Total Receivables amounts to 712.9m USD.
What is Bruker Corp's Total Receivables growth rate?
Total Receivables CAGR 10Y
10%
Over the last year, the Total Receivables growth was 47%. The average annual Total Receivables growth rates for Bruker Corp have been 24% over the past three years , 15% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
